41 related articles for article (PubMed ID: 27211282)
21. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
[TBL] [Abstract][Full Text] [Related]
22. Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.
Amin SS; Jalal SD; Ali KM; Mohammed AI; Rasool LK; Osman TJ
Biomed Res Int; 2020; 2020():2807120. PubMed ID: 32190657
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.
Adekile AD; Azab AF; Al-Sharida SI; Al-Nafisi BA; Akbulut N; Marouf RA; Mustafa NY
Hemoglobin; 2015; 39(5):320-6. PubMed ID: 26076396
[TBL] [Abstract][Full Text] [Related]
24. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.
Musallam KM; Cappellini MD; Wood JC; Motta I; Graziadei G; Tamim H; Taher AT
Haematologica; 2011 Nov; 96(11):1605-12. PubMed ID: 21791471
[TBL] [Abstract][Full Text] [Related]
25. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
Yavarian M; Karimi M; Bakker E; Harteveld CL; Giordano PC
Haematologica; 2004 Oct; 89(10):1172-8. PubMed ID: 15477200
[TBL] [Abstract][Full Text] [Related]
26. Hemoglobin e syndromes.
Vichinsky E
Hematology Am Soc Hematol Educ Program; 2007; ():79-83. PubMed ID: 18024613
[TBL] [Abstract][Full Text] [Related]
27. [Advances in Pathogenesis and Related Clinical Research of Thromboembolism in Patients with Thalassemia after Splenectomy].
Sun N; Cheng P; Deng DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):949-53. PubMed ID: 27342540
[TBL] [Abstract][Full Text] [Related]
28. The definition and epidemiology of non-transfusion-dependent thalassemia.
Weatherall DJ
Blood Rev; 2012 Apr; 26 Suppl 1():S3-6. PubMed ID: 22631040
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors for the Occurrence of Asymptomatic Brain Lesions in Patients with β-Thalassemia: a Systematic Review and Meta-Analysis.
Haghpanah S; Hosseini-Bensenjan M; Sayadi M; Karimi M; Ramzi M; Movahed H; Eghtedari M
Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307134
[TBL] [Abstract][Full Text] [Related]
30. Economic Burden of Transfusion Dependent Thalassemia.
Choudhry VP
Indian J Pediatr; 2018 May; 85(5):329-330. PubMed ID: 29516378
[No Abstract] [Full Text] [Related]
31. Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia Patients.
Karimi M; Jooya P; Haghpanah S; Mokhtari M; Rezaei N; Fath M; Parand S
Hemoglobin; 2016 Aug; 40(4):250-6. PubMed ID: 27211282
[TBL] [Abstract][Full Text] [Related]
32. Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.
Ehsani MA; Hedayati-Asl AA; Bagheri A; Zeinali S; Rashidi A
Pediatr Hematol Oncol; 2009 Nov; 26(8):560-5. PubMed ID: 19954365
[TBL] [Abstract][Full Text] [Related]
33. Hydroxyurea in the management of thalassemia intermedia.
Karimi M
Hemoglobin; 2009; 33 Suppl 1():S177-82. PubMed ID: 20001623
[TBL] [Abstract][Full Text] [Related]
34. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
